SCH 721015

BIOLOGICAL4 trials

Sponsors

University of Pennsylvania, Abramson Cancer Center at Penn Medicine, M.D. Anderson Cancer Center

Conditions

Bladder CancerMalignant Pleural MesotheliomaMesotheliomaMetastatic Pleural EffusionsPleural Mesothelioma

Phase 1

Gene Therapy for Pleural Malignancies

CompletedNCT00299962

University of PennsylvaniaMetastatic Pleural Effusions, Pleural Mesothelioma

Start: 2006-03-31End: 2009-10-31Updated: 2020-03-18

Combination Gene Transfer and Chemotherapy

CompletedNCT01119664

Abramson Cancer Center at Penn MedicineMesothelioma

Start: 2010-04-27End: 2017-03-17Updated: 2020-03-17

1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer

CompletedNCT01162785

M.D. Anderson Cancer CenterBladder Cancer

Start: 2011-04-30End: 2016-11-30Updated: 2016-11-28

Intrapleural Gene Transfer for Pleural Mesothelioma

CompletedNCT01212367

Abramson Cancer Center at Penn MedicineMalignant Pleural Mesothelioma

Start: 2009-02-28End: 2015-05-31Updated: 2015-09-22